Trade Review
Play: Gap and Crap Reversal on a Biotech with Phase 2 news
Big Picture:
Scanner:
Technical Analysis:
Intraday Chart:
Thesis for the trade:
Traded it off the first support level, but it was after it had gone below it, so was trading more of a zone but below the support level, hindsight no real reason for shorts to cover there, hence why it probably never did a reversal there
Trade Management: Managed the trade according to my plan, stuck my risk level, executed and moved on
Price Target(s): $1.67 and $1.85
Stop: $1.38
What Do I Need to Improve: Really thinking like a shorter, and where they may look to cover, will give me a better odds of finding where the reversal could happen. Granted this one never had a reversal, maybe as the market has been weaker and there was an offering in progress
Thoughts on the Trade After Being Executed: If I was playing the first target, VWAP, the risk to reward wasn't the very best, 3:1. No real reason for shorts to cover, on to the next
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2024-04-15 09:39:27 | ONVO | buy | $1.419 | long |
2024-04-15 09:39:39 | ONVO | sell | $1.380 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!